STAT

JANUARY 5, 2024

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years. Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “ authorized generic ,” essentially the same product sold under a private label.

Labelling 309

Labelling Drug Pricing 309

PharmaVoice

JANUARY 5, 2024

Although three companies dominate the space, emerging infectious disease focus areas and a handful of other key players are augmenting the market.

265

265

STAT

JANUARY 5, 2024

In December 2022, Congress repealed the “X-waiver” requirement, which had limited medical providers’ ability to prescribe buprenorphine-naloxone, one of the three medications approved by the Food and Drug Administration for the treatment of opioid use disorder. Lawmakers knew that the waiver was a major barrier to providing lifesaving medication that halves the risk of overdose to the millions of Americans needing treatment for opioid use disorder.

301

301

ALiEM - Pharm Pearls

JANUARY 5, 2024

Dr. Sara Krzyzaniak (podcast host and Stanford University PD) and Dr. Michelle Lin (ALiEM Founder/UCSF) are joined by Dr. Aaron Kraut (University of Wisconsin PD) in this insightful, rapid-fire, practical episode through the lens of experienced residency program directors. What does the Electronic Residency Application Service (ERAS) preliminary data show just far for the 2024 residency application season?

Communication 174

Communication 174

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 5, 2024

Maddy Welz always loved to dance. Even before she learned how to tie her own shoes, she was performing pliés and practicing tap steps. But her life changed when she was diagnosed with scoliosis at the age of 14. Caught during a scoliosis screening at school, the diagnosis was unexpected. “We were really surprised because I had shown no signs of it before,” said Welz, who’s now 16 years old and lives with her family in Boston.

299

299

BioPharma Dive

JANUARY 5, 2024

The clearance is a major shift for the agency, which described its decision as a “first step” in allowing Florida to bulk purchase lower-cost Canadian medicines.

120

120

pharmaphorum

JANUARY 5, 2024

Explore the highlights of the 2023 Benchling biotech press roundtable before Benchtalk London, showcasing cutting-edge software and innovations in the field of biotechnology.

110

110

STAT

JANUARY 5, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Today, we discuss why a cell therapy stalwart is pivoting, and why a Feng Zhang startup is laying off a quarter of its staff. Also, Novartis is using some of its GLP-1 windfall to invest in Flagship Pioneering startups in the cardiometabolic space.

Drug Development 237

Drug Development 237

Pharmaceutical Commerce

JANUARY 5, 2024

LillyDirect will facilitate access to medications by connecting patients with independent telehealth providers, bypassing the need to obtain a prescription from a physician and then going to a pharmacy to fill it.

105

105

STAT

JANUARY 5, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

222

222

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

JANUARY 5, 2024

Under a new licensing agreement, Stemline Therapeutics, Inc., a wholly-owned subsidiary of the Menarini Group, gains the global rights to develop and commercialise a novel, small molecule KAT6A inhibitor. This treatment has potential for hormone sensitive cancers such as breast cancer, and other oncology indications. The therapeutic is designed using the artificial intelligence (AI)-platform from Insilico Medicine, the biotech company that is also part of this collaboration.

105

105

STAT

JANUARY 5, 2024

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, catch up on our reading, and take a nap or two. We also hope to hold another listening party with Mrs.

Diabetes 191

Diabetes Medical Records Pharmaceutical Companies Pharmaceutical Companies 191

BioPharma Dive

JANUARY 5, 2024

Lykos Therapeutics, formerly known as MAPS Public Benefit Corp., recently submitted its MDMA capsules for FDA approval, following two positive studies.

112

112

pharmaphorum

JANUARY 5, 2024

Gain insights from sustainability leaders in the life sciences industry on navigating the path to sustainable pharma. Learn about their efforts in addressing environmental issues, social impact, governance practices, and enhancing patient outcomes.

99

99

Pharmaceutical Technology

JANUARY 5, 2024

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

122

122

The Pharmacist

JANUARY 5, 2024

Menopause campaigners have called for NICE guidelines on the menopause to include more ‘balanced’ wording around the benefits of hormone replacement therapy (HRT), as well as for more consideration and detail to be given to the use of testosterone. In a consultation response published yesterday, campaign group Menopause Mandate also said that the guidelines contained […] The post Draft NICE menopause guidelines ‘seriously lacking’, say campaigners appeared first on The Pharmacist.

99

99

pharmaphorum

JANUARY 5, 2024

Beckley Psytech has announced that is has received substantial strategic investment from atai Life Sciences, totalling $50 million, to accelerate the clinical development of short-duration psychedelics.

84

84

The Pharmacist

JANUARY 5, 2024

The pharmacy regulator has acknowledged 'serious concerns' raised by a BBC report into online pharmacies and has pledged to investigate the issue further. An undercover BBC reporter was able to obtain a potentially fatal dose of anti-anxiety medicine, as well as other restricted drugs supplied without checks such as access to medical records or GP […] The post Regulator to ‘urgently look into’ BBC online pharmacy claims appeared first on The Pharmacist.

Online Pharmacies 82

Online Pharmacies Medical Records 82

Pharma Times

JANUARY 5, 2024

The companies will aim to select targets, discover and develop new therapeutics

113

113

The Pharmacist

JANUARY 5, 2024

The reduction in Category M reimbursement outlined in the January drug tariff could ‘hamper’ the successful launch of Pharmacy First in England, the sector’s negotiator has warned. Though the margin adjustment was expected to be greater than the eventual 9% outcome, Community Pharmacy England (CPE) has argued that, given the ongoing pressures on the sector […] The post Drug tariff reduction could ‘hamper’ Pharmacy First, CPE warns appeared first on The Pharmacist.

Community Pharmacies 86

Community Pharmacies 86

Pharma Times

JANUARY 5, 2024

Vd1-gd T cells were effective in predicting positive responses to ICI therapy

Immunity 113

Immunity Immunization Hospitals 113

World Pharma News

JANUARY 5, 2024

In a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia have cracked the code behind IKAROS, an essential protein for immune cell development and protection against pathogens and cancer. This disruptive research, led by the eminent Professor Nicholas Huntington of Monash University's Biomedicine Discovery Institute, is poised to reshape our comprehension of gene control networks and its impact on everything fr

Immunity 81

Immunity Immunization 81

The Guardian - Pharmaceutical Industry

JANUARY 5, 2024

Pedro, five, was diagnosed with neuroblastoma; a fund has been set up so that his family can afford expensive chemotherapy drug Leading artists, Indigenous activists and politicians across Brazil are urging people to contribute to a fund to help the son of the slain Amazon activist Bruno Pereira , who has been diagnosed with a rare form of cancer. Pedro Pereira, five, the son of anthropologist Beatriz Matos and Bruno Pereira – who was ambushed and killed in the western Amazon in June 2022 alongs

Chemotherapy 80

Chemotherapy 80

PharmExec

JANUARY 5, 2024

The LillyDirect platform will allow patients who are prescribed the popular weight loss drug Zepbound to obtain the drug via Lilly’s at-home prescription delivery service.

96

96

Pharmafile

JANUARY 5, 2024

Rhythm Pharmaceuticals and LG Chem Life Sciences have announced that they have entered into a global licensing agreement for LB54640, an investigational oral small molecule melanocortin-4 receptor (MC4R) agonist which is currently in phase 2 clinical trials. A phase 1 trial of the candidate in healthy overweight adults demonstrated dose-dependent weight reduction.

63

63

Drug Patent Watch

JANUARY 5, 2024

Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Bausch drug BRYHALI appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmafile

JANUARY 5, 2024

Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine and diabetes. This is intended to offer resources around disease management, such as access to healthcare providers, tailored support and delivery of selected medications. The programme will provide patients with LillyDirect Pharmacy Solutions, a digital […] The post Eli Lilly launches digital healthcare process appeared first on Pharmafile.

Diabetes 58

Diabetes 58

PharmaState Academy

JANUARY 5, 2024

The Quiz competition is on! Participate Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification.

52

52

Pharmaceutical Commerce

JANUARY 5, 2024

Trials will evaluate four novel agents for cancers that include essential thrombocythemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, non-small cell lung cancer, endometrial carcinoma, and metastatic castration-resistant prostate cancer.

52

52

PharmaState Academy

JANUARY 5, 2024

The Quiz competition is on! Participate Now! Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification. The winner will be announced after profile verification. Once you're a winner, you will not be considered for the prizes for another two months. Note: You can participate only 1 time. Participation by using another name & email id will lead to disqualification.

52

52

PharmExec

JANUARY 5, 2024

Tina Fresta, BA, MPH is the Strategic Solutions Senior Manager at epocrates, keeps a close eye on the pharmaceutical and bio science industry shifts, leveraging those insights to inform both our partners and our company of the most strategic approach to reach business goals.

52

52

Pharma and Life Sciences Blog

JANUARY 5, 2024

Chemicals Giant Achieves Huge Savings With GEP's Expertise annmarie@AZglo… Fri, 01/05/2024 - 19:01 For a U.K. chemicals giant, enhancing its procurement processes was high on its priority list to maintain a cost-effective supply chain. Plagued by a number of operational challenges, it wanted to refine its direct materials cost structure, manage scattered data and negotiate with a global supplier network to achieve substantial cost savings.

52

52

RX Note

JANUARY 5, 2024

Introduction The smartphone market overflows with options, from years-old handsets to gleaming new flagships. Consequently, picking the perfect one can quickly turn into a head-scratching ordeal. Key Considerations Price You should not sell a kidney for a mobile phone! If you are on a tight budget, focus on your essential needs and avoid unnecessary bells and whistles.

52

52

Pharma Mirror

JANUARY 5, 2024

New Delhi, India – FD-AID, LLC, a distinguished leader in pharmaceutical quality and compliance solutions, proudly announces its entry into the Indian pharmaceutical market. Spearheaded by a former US FDA Investigator and seasoned pharmaceutical executive, FD-AID is uniquely positioned to bring a wealth of expertise and insight to India’s rapidly growing pharmaceutical industry.

52

52

Pharmaceutical Technology

JANUARY 5, 2024

Intellia Therapeutics announced its clinical goals for the next few years, pushing development for its late-stage ATTR asset.

64

64